Hiscox PLC
14 April 2003
14 April 2003
FOR IMMEDIATE RELEASE
Hiscox plc
Share Allotment
The Board of Hiscox plc hereby advises that on 14 April 2003 it has allotted the
following ordinary shares of 5p each at exercise prices set out below following
the exercise of options under the following schemes:
Hiscox Holdings Inland Revenue Approved and Unapproved Share Option Schemes
Approved Exercise Price
52,882 £0.314
Unapproved Exercise Price
592,273 £1.095
Subsequent to the exercise of 528,816 of the unapproved share options above, B E
Masojada will have 2,317,808 beneficial shares or 0.8% of the issued share
capital of Hiscox plc.
Also on 14 April 2003, the Board of Hiscox plc allotted 1,795 ordinary shares of
5p each at an exercise price of £1.078 following the exercise of options under
the Sharesave Scheme.
The total number of shares allotted was 646,950. These shares will rank pari
passu with the existing class of ordinary 5p shares in issue.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.